| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 19.892 | 42.613 | 30.938 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 19.892 | 42.613 | 30.938 |
| Total Expenses - EUR | - | - | - | - | - | - | 216 | 8.433 | 12.022 | 21.227 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -216 | 11.458 | 30.591 | 9.711 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -216 | 11.144 | 30.165 | 9.401 |
| Employees | - | - | - | - | - | - | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Prodermalex S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 13.008 | 11.954 | 11.981 | 10.500 |
| Current Assets | - | - | - | - | - | - | 6.834 | 3.941 | 29.805 | 40.357 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 40 | 41 | 629 | 71 |
| Cash | - | - | - | - | - | - | 6.794 | 3.900 | 29.176 | 40.286 |
| Shareholders Funds | - | - | - | - | - | - | -175 | 10.968 | 41.100 | 50.271 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 20.018 | 4.926 | 687 | 586 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9622 - 9622" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Prodermalex S.r.l.